COVID-19 Drug Development Recent Advances, New Perspectives and Applications

COVID-19 is a rampant worldwide problem. It is caused by the SARS-CoV-2 virus and is manifest in different variants. The Delta variant compromised existing therapeutic and preventive options for this disease and is beginning to be replaced by the Omicron variant. Through pharmaceutical biotechnology...

Full description

Saved in:
Bibliographic Details
Other Authors: Aditya Parikesit, Arli (Editor)
Format: Electronic Book Chapter
Language:English
Published: IntechOpen 2022
Subjects:
Online Access:DOAB: download the publication
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000naaaa2200000uu 4500
001 doab_20_500_12854_97255
005 20230215
003 oapen
006 m o d
007 cr|mn|---annan
008 20230215s2022 xx |||||o ||| 0|eng d
020 |a intechopen.100969 
020 |a 9781803569901 
020 |a 9781803569895 
020 |a 9781803569918 
040 |a oapen  |c oapen 
024 7 |a 10.5772/intechopen.100969  |c doi 
041 0 |a eng 
042 |a dc 
072 7 |a MMG  |2 bicssc 
100 1 |a Aditya Parikesit, Arli  |4 edt 
700 1 |a Aditya Parikesit, Arli  |4 oth 
245 1 0 |a COVID-19 Drug Development  |b Recent Advances, New Perspectives and Applications 
260 |b IntechOpen  |c 2022 
300 |a 1 electronic resource (166 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a COVID-19 is a rampant worldwide problem. It is caused by the SARS-CoV-2 virus and is manifest in different variants. The Delta variant compromised existing therapeutic and preventive options for this disease and is beginning to be replaced by the Omicron variant. Through pharmaceutical biotechnology, three different treatment approaches to COVID-19 have been developed: computer-aided drug design (CADD); rational drug design in the wet lab; and the advanced drug delivery system. These approaches are heavily influenced by advances in life sciences, such as the development of structural bioinformatics, the establishment of nanobiotechnology as a standard approach in drug design, and major advances in structural biology such as the development of the CryoEM method. This book will focus on providing possible solutions to the ongoing COVID-19 pandemic in light of these advances in life sciences. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/3.0/  |2 cc  |4 https://creativecommons.org/licenses/by/3.0/ 
546 |a English 
650 7 |a Pharmacology  |2 bicssc 
653 |a Other branches of medicine 
856 4 0 |a www.oapen.org  |u https://mts.intechopen.com/storage/books/11690/authors_book/authors_book.pdf  |7 0  |z DOAB: download the publication 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/97255  |7 0  |z DOAB: description of the publication